Here is something akin to a conspiracy theory.
IMUC is on a tear. I've not invested in it, however, they have phase II stats that will achieve statistical significance for OS in dendritic treatment any month now. Its just a matter of time….no doubt.
So, the investment in IMUC is a cagey multiplier play.
Here is how it goes:
If NWBO has bad results, IMUC is the last man standing in its niche.
If NWBO succeeds, IMUC becomes a huge takeover target by big pharma (in order to compete with NWBO).
At one dollar a share, people realize how fast their cheap shares can exponentially grow.
So IMUC is going crazy in anticipation of NWBO news.
On the other hand, NWBO is temporarily in a more unknown state than IMUC…..just for a short window. Investors already see the potential in NWBO, but NWBO is closer to 2 binary events than IMUC right now. IMUC has midterm upsides no matter the upcoming results for NWBO.
Nonetheless, NWBO also moved today because:
1. Results are expected anytime between today and early February.
2. Another dendritic stock went crazy (IMUC).
3. People and institutions are waking up.